查看购物车
  • Traditional Chinese
  • English
肱骨外上髁炎治疗市场规模、份额及成长分析（按治疗方法、最终用户和地区划分）－2026-2033年产业预测
市场调查报告书
商品编码
1914022

肱骨外上髁炎治疗市场规模、份额及成长分析（按治疗方法、最终用户和地区划分）－2026-2033年产业预测

Lateral Epicondylitis Treatment Market Size, Share, and Growth Analysis, By Treatment Type (Non-Surgical Treatments, Surgical Treatments), By End User (Hospitals, Specialty Clinics), By Region - Industry Forecast 2026-2033.
出版日期: | 出版商: SkyQuest | 英文 172 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球外侧肘关节症候群治疗市场规模预计在 2024 年达到 12.5 亿美元，从 2025 年的 13 亿美元成长到 2033 年的 18.1 亿美元，在预测期（2026-2033 年）内复合年增长率为 4.2%。

由于重复性劳损的发生率不断上升，尤其是在运动员、体力劳动者和上班族中，全球肱骨外上髁炎治疗市场正经历显着增长。微创治疗方法（例如富血小板血浆注射和衝击波疗法）的出现，拓展了治疗选择，同时人们对预防措施的认识也不断提高。此外，再生医学的进步和门诊手术中心的普及，也改善了患者获得治疗的机会。人口老化以及人们对早期疗育益处的认识不断提高，进一步推动了市场扩张。在持续成长的需求背景下，肱骨外上髁炎的治疗方案正变得越来越多样化，也越来越容易获得。

全球肱骨外上髁炎治疗市场驱动因素

肱骨外上髁炎在运动员、体力劳动者和上班族的发生率不断上升，这主要是由于重复性动作活动的频率增加所致，也是推动市场成长的因素。病例激增导致人们对各种治疗方案的需求增加，从矫正器具和物理治疗等非手术干预到关节镜等外科手术。这一趋势在已开发地区尤其明显，这些地区积极老化日益受到重视，进一步推动了对有效治疗方法的需求，以控制和缓解这种疾病。

限制全球肱骨外上髁炎治疗市场的因素

全球肱骨外上髁炎治疗市场面临严峻挑战，主要原因是富血小板血浆（PRP）疗法、干细胞疗法和衝击波疗法等生物疗法高成本。这些先进的治疗方法通常不在医疗保险范围内，尤其是在发展中地区，这对寻求有效治疗的患者造成了经济障碍。因此，许多患者可能会选择价格较低的非生物疗法（例如皮质类固醇注射），这可能会阻碍创新治疗方法在市场上的广泛应用，并限制肱骨外上髁炎的整体治疗选择。

全球肱骨外上髁炎治疗市场趋势

全球肱骨外上髁炎治疗市场正经历着向再生医学的显着转变，其特点是富血小板血浆（PRP）疗法、干细胞注射和基于生长因子的疗法等生物疗法的接受度不断提高。这些创新疗法因其能够促进组织自然修復并降低復发风险而备受关注，并成为传统治疗方法的更佳替代方案。这一趋势在北美和欧洲尤为明显，这些地区的医疗保健系统开始认可并支持整合这些先进治疗方法，反映出医疗机构致力于改善肌腱疾病患者的治疗效果。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数（2025）
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 案例研究
  • 顾客购买行为分析

全球肱骨外上髁炎治疗市场规模：依治疗方法及复合年增长率（2026-2033 年）划分

  • 非手术治疗方法
    • 药物治疗
    • 物理治疗
    • 矫正器具和支架
    • 其他非手术治疗方法
  • 手术治疗方法
    • 关节镜手术
    • 开放性手术
    • 其他治疗方法

全球肱骨外上髁炎治疗市场规模（按年龄层划分）及复合年增长率（2026-2033 年）

  • 儿童
  • 成人版
  • 老年人

全球肱骨外上髁炎治疗市场规模（按最终用户划分）及复合年增长率（2026-2033 年）

  • 医院
  • 专科诊所
  • 门诊手术中心
  • 居家医疗环境

全球肱骨外上髁炎治疗市场规模及复合年增长率（2026-2033）

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位（2025 年）
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析（2025 年）
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Teikoku Pharma, Inc.
  • Kasiak Research Pvt. Ltd.
  • Molecular Pharmacology Limited
  • Chugai Pharmaceutical Co., Ltd.
  • Seikagaku Corporation
  • OMRON Corporation
  • BioMedical Life Systems, Inc.
  • Zynex, Inc.
  • EMS Physio Ltd.
  • DJO Global, Inc.
  • Beurer GmbH
  • 3M
  • AKSIGEN
  • BTL Corporate

结论与建议

简介目录
Product Code: SQMIG45N2126

Global Lateral Epicondylitis Treatment Market size was valued at USD 1.25 Billion in 2024 and is poised to grow from USD 1.3 Billion in 2025 to USD 1.81 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

The global market for lateral epicondylitis treatment is experiencing notable growth due to a rising incidence of repetitive strain injuries, particularly among athletes, manual laborers, and office workers. The availability of minimally invasive treatment options, such as PRP injections and shockwave therapy, is enhancing therapeutic choices while awareness of preventive measures is increasing. Furthermore, advancements in regenerative medicine and the proliferation of ambulatory surgical centers are improving access to care for affected individuals. The expanding elderly population, alongside a heightened recognition of the benefits of early intervention, is further driving market expansion. As demand continues to grow, the landscape of treatment options for lateral epicondylitis is becoming increasingly diverse and accessible.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lateral Epicondylitis Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lateral Epicondylitis Treatment Market Segments Analysis

Global Lateral Epicondylitis Treatment Market is segmented by Treatment Type, End User and region. Based on Treatment Type, the market is segmented into Non-Surgical Treatments and Surgical Treatments. Based on End User, the market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgical Centres and Homecare Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lateral Epicondylitis Treatment Market

The rising prevalence of lateral epicondylitis among athletes, manual laborers, and office workers serves as a significant driver for the market, largely due to the growing frequency of repetitive motion activities. This surge in cases has led to a heightened demand for a variety of treatment options, encompassing non-surgical interventions such as braces and physiotherapy, as well as surgical procedures like arthroscopic release. The trend is particularly pronounced in developed regions where there is a notable focus on active aging populations, further propelling the need for effective treatments tailored to manage and alleviate this condition.

Restraints in the Global Lateral Epicondylitis Treatment Market

The Global Lateral Epicondylitis Treatment market faces significant challenges due to the high costs associated with biologic therapies such as platelet-rich plasma (PRP) and stem cell treatments, as well as shockwave therapies. These advanced treatment options are often not covered by insurance, particularly in lesser-developed regions, creating a financial obstacle for patients seeking effective care. As a result, many individuals may opt for more affordable, non-biologic alternatives, such as corticosteroid injections, which can impede the broader acceptance and application of these innovative therapies within the market, limiting overall treatment options for lateral epicondylitis.

Market Trends of the Global Lateral Epicondylitis Treatment Market

The Global Lateral Epicondylitis Treatment market is witnessing a notable shift towards regenerative medicine, characterized by the increasing acceptance of biologic therapies such as platelet-rich plasma (PRP) therapy, stem cell injections, and growth factor-based treatments. These innovative solutions are gaining traction due to their ability to enhance natural tissue repair and reduce the likelihood of recurrence, positioning them as preferable alternatives to traditional treatments. This trend is especially prominent in North America and Europe, where healthcare systems are beginning to recognize and support the integration of these advanced therapeutic modalities, reflecting a broader commitment to improving patient outcomes in tendinopathies.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Customer Buying Behavior Analysis

Global Lateral Epicondylitis Treatment Market Size by Treatment Type & CAGR (2026-2033)

  • Market Overview
  • Non-Surgical Treatments
    • Medications
    • Physical therapy
    • Orthotics and braces
    • Other non-surgical treatments
  • Surgical Treatments
    • Arthroscopic surgery
    • Open surgery
    • Other surgical treatments

Global Lateral Epicondylitis Treatment Market Size by Age Group & CAGR (2026-2033)

  • Market Overview
  • Pediatric
  • Adult
  • Geriatric

Global Lateral Epicondylitis Treatment Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centres
  • Homecare Settings

Global Lateral Epicondylitis Treatment Market Size & CAGR (2026-2033)

  • North America (Treatment Type, Age Group, End User)
    • US
    • Canada
  • Europe (Treatment Type, Age Group, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Treatment Type, Age Group, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Treatment Type, Age Group, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Treatment Type, Age Group, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Teikoku Pharma, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kasiak Research Pvt. Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Molecular Pharmacology Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Chugai Pharmaceutical Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Seikagaku Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • OMRON Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioMedical Life Systems, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zynex, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • EMS Physio Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DJO Global, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beurer GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3M
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AKSIGEN
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BTL Corporate
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations